BIOCAD is Russia's leading innovative biotechnology company; it combines a world-class research and development center, ultra-modern pharmaceutical and biotechnological manufacturing facilities, as well as preclinical and clinical research infrastructure compliant with international standards. BIOCAD is one of the world`s few full-cycle drug development and manufacturing companies, from new molecule discovery and genetic engineering to large-scale commercial production and marketing support. BIOCAD`s medicines are dedicated to treat complex health conditions such as cancer, HIV and Hepatitis C infections, multiple sclerosis and other disorders.
Looking for a particular BIOCAD employee's phone or email?
BIOCAD Questions
The BIOCAD annual revenue was $135.2 million in 2026.
Dmitry Morozov is the CEO of BIOCAD.
650 people are employed at BIOCAD.
BIOCAD is based in Petrodvorets, St.-Petersburg.
The NAICS codes for BIOCAD are [325, 32, 541, 541713, 54171, 5417, 54].
The SIC codes for BIOCAD are [873, 283, 28, 87].
Top BIOCAD Employees
-
Yulia Linkova
Vice President Clinical Research and Development at BIOCAD
Saint Petersburg, RU3 -
Krishnamurthy Rao
Managing Director at BIOCAD
Bengaluru, KA, IN21 -
Galina Efremova
CMO and Tech Transfer Group Leader (Russia and CIS) at BIOCAD
Saint Petersburg, RU3 -
Konstantin Semenov
Head of Clinical QA and QC Department at Biocad at BIOCAD
Saint Petersburg, RU31 -
Danila Streltsov
Vice President Legal and IP at BIOCAD
Saint Petersburg, RU1 -
Carlos Fernando Torres Sandoval
Country Head - GM at BIOCAD
Bogotá, Bogota, CO45+ -
Alexey Torgov
Vice President Corporate Relations and Communications at BIOCAD
Saint Petersburg, RU2 -
Pavel Yakovlev
VP of Research and Early Development at BIOCAD
Saint Petersburg, RU2
Related Companies
